Disease expression in Swiss Hereditary Non-Polyposis Colorectal Cancer (HNPCC) kindreds

International Journal of Cancer

Volumn 74, Issue 3, 1997, Pages 281-285

  Heinimann, Karl ^a,b   Müller, Hansjakob ^a   Weber, Walter ^a   Scott, Rodney J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BASE MISPAIRING; BASE PAIRING; CANCER SURVIVAL; COLORECTAL CANCER; DNA REPAIR; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; ENDOMETRIAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK; SEX DISTRIBUTION; STOMACH NEOPLASMS; SWITZERLAND;

EID: 0030861748     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970620)74:3<281::AID-IJC8>3.0.CO;2-V     Document Type: Article

References (33)

1. AALTONEN, L.A. and 13 OTHERS, Clues to the pathogenesis of familial colorectal cancer. Science, 260, 812-816 (1993).
2. AALTONEN, L.A., SANKILA, R., MECKLIN, J.-R. JÄRVINEN, H., PUKKALA, E., PELTOMÄKI, P. and DE LA CHAPELLE, A., A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect. Prevent., 18, 57-63 (1994).
3. AARNIO, M., MECKLIN, J.-P, AALTONEN, L.A., NYSTRÖM-LAHTI, M. and JÄRVINEN, H.J., Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer, 64, 430-433 (1995).
4. BERRINO, F., SANT, M., VERDECCHIA. A., CAPOCACCIA, R., HAKULINEN, T. and ESTEVE, J. (eds.), Survival of cancer patients in Europe: The EURO-CARE study, p. 191, IARC Scientific Publications 132, IARC. Lyon (1995).
5. BISHOP, D.T., BRCA1, BRCA2, BRCA3 ... a myriad of breast cancer genes. Europ. J. Cancer, 30A, 1738-1739 (1994).
6. BUERSTEDDE, J.M., ALDAY, P., TORHORST, J., WEBER, W., MÜLLER. H.J. and SCOTT, R.J., Detection of new mutations in 6 out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes, J. med. Genet., 32, 909-912 (1995).
7. FISHEL, R., LESCOE, M.K., RAO, M.R., COPELAND, N.G., JENKINS, N.A., GARBER, J., KANE, M. and KOLODNER, R., The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell, 75, 1215-1225 (1993).
8. HALL, N.R., MURDAY, V.A., CHAPMAN, P., WILLIAMS, M.A.T., BURN, J., FINAN, P.J. and BISHOP, D.T., Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Europ. J. Cancer, 30A, 180-182 (1994).
9. HAMILTON, S.R. and 18 OTHERS, The molecular basis of Turcot's syndrome. New Engl. J. Med., 332, 839-847 (1995).
10. JÄRVINEN, H.J., AARNIO, M. and MECKLIN, J.-P., Prognostic difference of colorectal cancer in various high-risk conditions. ICG-HNPCC Eighth Annual Meeting, Buffalo, NY (1996).
11. KOLODNER, R.D. and 12 OTHERS, Structure of the human MHL1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for hMLH1 mutations. Cancer Res., 55, 242-248 (1995).
12. KONISHI, M. and 15 OTHERS, Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis and sporadic colon cancer. Gastroenterology. 11, 307-317 (1991).
13. LEACH, F.S. and 34 OTHERS, Mutations in a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75, 1215-1225 (1993).
14. LEVI, F., RAYMOND, L. and SCHULER, G. (eds.), Le cancer en Suisse: fréquence, mortalité et survie 1983-1987, pp. 17-18, Ligue suisse contre le cancer, Berne (1994).
15. LINDBLOM, A., TANNERGARD, P., WERELIUS, B. and NORDENSKJÖLD, M., Genetic mapping of a second locus predisposing to hereditary non-polyposis colorectal cancer. Nature Genet., 5, 279-282 (1993).
16. LIU, B. and 13 OTHERS, Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nature Med., 2, 169-174 (1996).
17. LYNCH, H.T., FUSARO, R.M., ROBERTS, L., VOORHEES, G. and LYNCH, J.F., Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Brit. J. Dermatol., 55, 499-502 (1985).
18. LYNCH, H.T., SMYRK, T. and LYNCH, J.F., Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int. J. Cancer, 69, 38-43 (1996).
19. LYNCH, H.T., SMYRK, T., WATSON, P., LANSPA, S.J., LYNCH, J.F., LYNCH, P.M., CAVALIERI, R.J. and BOLAND, R.C., Geneties, natural history, tumor spectrum and pathology of hereditary non-polyposis colorectal cancer: an updated review. Gastroenterology, 104, 1535-1549 (1993).
20. MARY, J.L., BISHOP, T., KOLODNER, R., LIPFORD, J.R., KANE, M., WEBER, W., TORHORST, J., MÜLLER, H.J., SPYCHER, M. and SCOTT, R.J., Mutational analysis of the hMSH2 gene reveals three base pair deletion in a family predisposed to colorectal cancer development. Hum. mol. Genet., 3, 2067-2069 (1994).
21. MECKLIN, J.-P., Frequency of hereditary colorectal cancer. Gastroenterology, 93, 1021-1021 (1987).
22. MERLO, A., ROCHLITZ, C. and SCOTT, R.J., Survival of patients with Turcot's syndrome and glioblastoma. New Engl. J. Med., 334, 736-737 (1996).
23. MODRICH, P. and LAHUE, R., Mismatch repair in replication fidelity, genetic recombination and cancer biology. Ann. Rev. Biochem., 65, 101-133 (1996).
24. NICOLAIDES, N.C. and 16 OTHERS, Mutations of two PMS homologues in hereditary non-polyposis colon cancer. Nature (Lond.), 371, 75-80 (1994).
25. NYSTRÖM-LAHTI, M. and 12 OTHERS, Founding mutations and ALU-mediated recombination in hereditary nonpolyposis colon cancer. Nature Med., 1, 1203-1206 (1995).
26. PALOMBO, F., GALLINARI, P., IACCARINO, J., TETTIERI, T., HUGHES, M., D'ARRIGO, A., TRUONG, O., HSUAN, J.J. and JIRICNY, J., GTBP, a 160-kD protein, essential for mismatch-binding activity in human cells. Science, 268, 1912-1914 (1995).
27. PAPADOPOULOS, N. and 18 OTHERS, Mutation of a MutL homolog in hereditary colon cancer. Science, 263, 1625-1629 (1994).
28. SANKILA, R., AALTONEN, L.A., JÄRVINEN, H.J. and MECKLIN, J.P., Better survival rates in patients with hMLH1-associated hereditary colorectal cancer. Gastroenterology, 110, 682-687 (1996).
29. SWISS CANCER REGISTRIES' ASSOCIATION DATABASE, Personal communication (1996).
30. VASEN, H.F.A., MECKLIN, J.-P., MEERA KHAN, P. and LYNCH, H.T., The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer. Dis. Colon Rectum, 34, 424-425 (1991).
31. VASEN, H.F.A. and 12 OTHERS, Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110, 1020-1027 (1996a).
32. VASEN, H.F.A., SANDERS, E.A.C.M., TAAL, B.G., NAGENGAST, F.M., GRIF-FIOEN, G., MENKO, F.H., KLEIBEUKER, J.H., HOUWING-DUISTERMAAT, J.J. and MEERA KHAN, P., The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int. J. Cancer, 65, 422-425 (1996b).
33. WATSON, P. and LYNCH, H.T., Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer, 71, 677-685 (1993).